Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAMP3 | O60896 | 13/20 | 0.42 |
| ▸ | CALCR | P30988 | 13/20 | 0.42 |
| ▸ | APLNR | P35414 | 2/20 | 0.42 |
| ▸ | NAA50 | Q9GZZ1 | 1/20 | 0.40 |
| ▸ | NMUR2 | Q9GZQ4 | 2/20 | 0.39 |
| ▸ | NMUR1 | Q9HB89 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22018529 | 0.94 | NAA50 (0.44) | RAMP3CALCRAPLNRNAA50NMUR2 | |
| SCHEMBL22018340 | 0.94 | APLNR (0.48) | RAMP3CALCRAPLNRNAA50NMUR2 | |
| SCHEMBL22018530 | 0.94 | APLNR (0.43) | RAMP3CALCRAPLNRNAA50NMUR2 | |
| SCHEMBL22018363 | 0.94 | APLNR (0.48) | RAMP3CALCRAPLNRNAA50NMUR2 | |
| SCHEMBL22018370 | 0.94 | APLNR (0.48) | RAMP3CALCRAPLNRNAA50NMUR2 | |
| SCHEMBL22018314 | 0.94 | APLNR (0.48) | RAMP3CALCRAPLNRNAA50NMUR2 | |
| SCHEMBL22018809 | 0.94 | APLNR (0.48) | RAMP3CALCRAPLNRNAA50NMUR2 | |
| SCHEMBL22018502 | 0.94 | APLNR (0.48) | RAMP3CALCRAPLNRNAA50NMUR2 | |
| SCHEMBL22018810 | 0.94 | APLNR (0.48) | RAMP3CALCRAPLNRNAA50NMUR2 | |
| SCHEMBL22018380 | 0.94 | APLNR (0.48) | RAMP3CALCRAPLNRNAA50NMUR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021191689-A2 | TREATMENT OF INFLAMMATORY DISEASES WITH PEPTIDES AND PHARMACEUTICAL COMPOSITIONS | YUYU PHARMA, INC. (KR) | 2021-09-30 | — | — | WO | disclosed |